Table 2. Antibody levels, days to treatment and in-hospital mortality, ventilation.

antibody levels, S/C median (IQR)	cohort
unit 1	5.92 (4.59–7.18)
unit 2	3.36 (2.38–5.11)
median	4.61 (3.65–6.09)
days to treatment a	1 (1–3.75)
	in-hospital mortality	alive	p
unit 1	5.92 (4.39–7.11)	5.91 (4.61–7.2)	0.981
unit 2	3.04 (1.98–5.2)	3.49 (2.39–5.05)	0.574
median	4.67 (3.29–6.09)	4.53 (3.65–6.08)	0.839
days to treatment a	2 (1–5.5)	1 (1–3)	0.259
	ventilation	no ventilation	p
unit 1	5.78 (4.41–7.08)	5.99 (4.61–7.18)	0.802
unit 2	3.39 (2.09–4.87)	3.32 (2.38–5.13)	0.980
median	4.41 (3.48–6.1)	4.65 (3.64–6.08)	0.835
days to treatment a	2 (0.75–6)	1 (1–3)	0.371
	ventilation or mortality	no ventilation or mortality	p
unit 1	5.87 (4.4–7.08)	5.96 (4.61–7.2)	0.852
unit 2	3.38 (2.03–5.14)	3.34 (2.38–5.11)	0.771
median	4.57 (3.38–5.95)	4.61 (3.65–6.09)	0.840
days to treatment a	2 (1–5.25)	1 (1–3)	0.339

^amedian (IQR).